Voyager Therapeutics, Inc.: accounts_payable
| Value | {"amount": 2634000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-03-31) |
| Status | current |
| Entity | Voyager Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:52:26.662251+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/33688d97-09b9-4d7b-a5be-6457bdb07bd2
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-25-006484 · Open the official SEC filing →Retrieved: 2026-08-19T16:52:26.662251+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001640266/accounts-payable/2025-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/33688d97-09b9-4d7b-a5be-6457bdb07bd2
History
- no predecessors — first report